Phase 1Completed
Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study
A Randomized, Open-label, Two-way Crossover Clinical Trial to Evaluate the Food Effect on Pharmacokinetics and SafEty of DHP107 (Oral Paclitaxel, Liporaxel®) in Patients With Advanced Solid Tumors (FEEL) / EudraCT no : 2020-004976-16
- Sponsor
- Daehwa Pharmaceutical Co., Ltd. (Industry)
- Enrolment
- 25 enrolled
- Conditions
- Advanced Solid Tumor
- Interventions
- DHP107(Oral paclitaxel)
- Ages
- adults, older adults
- Registry
- NCT04675528
Full record on ClinicalTrials.gov
From the registry
To evaluate the food effect on pharmacokinetics of DHP107 in patients with advanced solid tumors.
Primary outcomes
- • Cmax
- • Tmax
History
Last registry update
Primary completion
Started
Registered